{"title": "PRESS RELEASE: Novartis International Says U.S. Approves Tasigna Cancer Drug", "author": null, "url": "https://www.fiercebiotech.com/biotech/press-release-novartis-international-says-u-s-approves-tasigna-cancer-drug", "hostname": "fiercebiotech.com", "description": "Novartis International Says U.S. Approves Tasigna Cancer Drug BASEL, SWITZERLAND -- Oct 29, 2007 -- Tasigna\u00c2\u00ae (nilotinib) has been approved in the US as a new anti-cancer therapy for certain | Novartis International Says U.S. Approves Tasigna Cancer Drug BASEL, SWITZERLAND -- Oct 29, 2007 -- Tasigna\u00c2\u00ae (nilotinib) has been approved in the US as a new anti-cancer therapy for certain", "sitename": "FierceBiotech", "date": "2007-10-30", "cleaned_text": "Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Subscribe Biotech Cell & Gene Therapy Clinical Data Venture Capital Deals Research Medtech Devices Diagnostics AI and Machine Learning CRO Special Reports Fierce 50 Resources Fierce Events Industry Events Webinars Podcasts Whitepapers Survey Events Subscribe Fierce Pharma Fierce Biotech Fierce Healthcare Fierce Life Sciences Events Advertise About Us "}